Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Statistics

Total Valuation

KOSDAQ:175250 has a market cap or net worth of KRW 81.09 billion. The enterprise value is 115.36 billion.

Market Cap	81.09B
Enterprise Value	115.36B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:175250 has 37.37 million shares outstanding. The number of shares has decreased by -0.19% in one year.

Current Share Class	37.37M
Shares Outstanding	37.37M
Shares Change (YoY)	-0.19%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	15.22%
Owned by Institutions (%)	0.29%
Float	31.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.97
PB Ratio	1.58
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.53
EV / Sales	1.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.28

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.86.

Current Ratio	0.63
Quick Ratio	0.40
Debt / Equity	0.86
Debt / EBITDA	n/a
Debt / FCF	-3.55
Interest Coverage	-4.24

Financial Efficiency

Return on equity (ROE) is -12.45% and return on invested capital (ROIC) is -9.61%.

Return on Equity (ROE)	-12.45%
Return on Assets (ROA)	-7.57%
Return on Invested Capital (ROIC)	-9.61%
Return on Capital Employed (ROCE)	-28.24%
Revenue Per Employee	399.14M
Profits Per Employee	-26.75M
Employee Count	210
Asset Turnover	0.59
Inventory Turnover	5.60

Taxes

Income Tax	-330.91M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.78% in the last 52 weeks. The beta is 0.66, so KOSDAQ:175250's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-24.78%
50-Day Moving Average	1,951.34
200-Day Moving Average	1,884.37
Relative Strength Index (RSI)	64.65
Average Volume (20 Days)	246,304

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:175250 had revenue of KRW 83.82 billion and -5.62 billion in losses. Loss per share was -150.00.

Revenue	83.82B
Gross Profit	8.00B
Operating Income	-17.32B
Pretax Income	-6.87B
Net Income	-5.62B
EBITDA	-9.59B
EBIT	-17.32B
Loss Per Share	-150.00

Balance Sheet

The company has 10.06 billion in cash and 44.15 billion in debt, giving a net cash position of -34.09 billion or -912.30 per share.

Cash & Cash Equivalents	10.06B
Total Debt	44.15B
Net Cash	-34.09B
Net Cash Per Share	-912.30
Equity (Book Value)	51.27B
Book Value Per Share	1,334.72
Working Capital	-25.02B

Cash Flow

In the last 12 months, operating cash flow was -8.24 billion and capital expenditures -4.19 billion, giving a free cash flow of -12.43 billion.

Operating Cash Flow	-8.24B
Capital Expenditures	-4.19B
Free Cash Flow	-12.43B
FCF Per Share	-332.57

Margins

Gross margin is 9.55%, with operating and profit margins of -20.67% and -6.70%.

Gross Margin	9.55%
Operating Margin	-20.67%
Pretax Margin	-8.20%
Profit Margin	-6.70%
EBITDA Margin	-11.44%
EBIT Margin	-20.67%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:175250 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.19%
Shareholder Yield	n/a
Earnings Yield	-6.93%
FCF Yield	-15.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 14, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Dec 14, 2022
Split Type	Forward
Split Ratio	1.2

Scores

KOSDAQ:175250 has an Altman Z-Score of -0.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.55
Piotroski F-Score	4